Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-001230 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
7,500
Total Value
$238,975.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 2,500 | $40.59 | $101,475.00 | 3,334 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Jan 5, 2026 | Sale | 2,500 | $55.00 | $137,500.00 | 834 | Direct | โ | View Details | |
Chief Commercial Officer | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 97,500 | Direct | โ | View Details |